Authors

• Bella S. Guerrouahen (ORCID: https://orcid.org/0000-0003-4124-4389)
• Katherine V. Ferry‐Galow
• Margaret C. Wheless
• Farshid Dayyani (ORCID: https://orcid.org/0000-0002-4970-5189)
• Alejandro Contreras (ORCID: https://orcid.org/0000-0001-6668-823X)
• Jordan Berlin (ORCID: https://orcid.org/0000-0001-7571-2385)
• Gregory D. Ayers
• Vaia Florou (ORCID: https://orcid.org/0000-0001-5558-753X)
• Anwaar Saeed (ORCID: https://orcid.org/0000-0001-8024-9401)
• Steven Gore (ORCID: https://orcid.org/0009-0004-5227-4502)
• Heloisa P. Soares (ORCID: https://orcid.org/0000-0002-5185-2583)
• Satya Das (ORCID: https://orcid.org/0000-0002-7625-1039)
• Shannon Stockton (ORCID: https://orcid.org/0000-0003-2799-663X)
• Liqing Li (ORCID: https://orcid.org/0000-0001-8297-309X)
• Edward Kim (ORCID: https://orcid.org/0000-0002-8660-7465)
• Ning Jin
• George Yacoub

Institutions

• Atrium Health Wake Forest Baptist (US)
• The University of Texas MD Anderson Cancer Center (US)
• Huntsman Cancer Institute (US)
• University of California, Irvine Medical Center (US)
• Therapeutics Clinical Research (US)
• Florida Cancer Specialists & Research Institute (US)
• UPMC Hillman Cancer Center (US)
• Frederick National Laboratory for Cancer Research (US)
• University of Pittsburgh Medical Center (US)
• National Cancer Institute (US)
• University of California Davis Medical Center (US)
• The Ohio State University (US)
• Vanderbilt University Medical Center (US)

Publication Details

Journal

The Oncologist

Published

2025-12-01

DOI

https://doi.org/10.1093/oncolo/oyaf400

Primary Topic

Cancer-related Molecular Pathways

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Merck KGaA
• National Institutes of Health
• EMD Serono
• National Cancer Institute